Dermatology Research Center, Inc   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Salt Lake City UT United States (1978)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2005
NCT00765583
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Dermatology Research Center, Inc. | Dermatology Research Institute, LLC | Dermatology Research Institute, LLC.

Active Ingredients

Drugs in Phase 4 Trials (1)

hyaluronic acid (1 trial)

Drugs in Phase 3 Trials (2)

betamethasone (celestone) (1 trial)

calcipotriene (dovonex) (1 trial)

Drugs in Phase 2 Trials (2)

nb-002 (1 trial)

rimabotulinumtoxinB (Myobloc) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Onychomycosis (Phase 2)

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5